Overview

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
UNLOCKED: A Phase 2 Trial to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care
Phase:
Phase 2
Details
Lead Sponsor:
Kaleido Biosciences